Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

Major ABO mismatching is not considered a contraindication to allogeneic haematopoietic stem cell transplantation (HSCT). Modern reduced-intensity conditioning and reduced-toxicity regimens cause much less myeloablation than conventional myeloablative regimens, such as cyclophosphamide with busulfan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aung, Fleur M., Lichtiger, Benjamin, Bassett, Roland, Liu, Ping, Alousi, Amin, Bashier, Qaiser, Ciurea, Stefan O., de Lima, Marcos J., Hosing, Chitra, Kebriaei, Partow, Nieto, Yago, Oran, Betul, Parmar, Simrit, Qazilbash, Muzaffar, Shah, Nina, Khouri, Issa, Champlin, Richard E., Popat, Uday
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4078723/
https://ncbi.nlm.nih.gov/pubmed/23330820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12210
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars